Published in J Virol on September 01, 2001
Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol (2005) 1.03
Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virol J (2009) 0.87
Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties. J Virol (2017) 0.75
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med (2000) 9.36
Hepatitis B virus immunopathogenesis. Annu Rev Immunol (1995) 8.62
Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (1995) 7.40
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology (1999) 5.79
T cell activation determined by T cell receptor number and tunable thresholds. Science (1996) 5.51
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med (2000) 4.98
Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol (2001) 4.48
Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med (1995) 3.98
Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med (1996) 3.86
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (1993) 3.83
Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology (1999) 3.73
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell (1994) 3.71
Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (1991) 3.58
Expression of two T cell receptor alpha chains: dual receptor T cells. Science (1993) 3.54
Models of T cell anergy: is there a common molecular mechanism? J Exp Med (1996) 3.07
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today (1993) 2.91
From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell (1999) 2.52
Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol (1991) 2.03
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest (1996) 1.96
Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J Immunol Methods (1985) 1.62
Differential antigen-processing pathways of the hepatitis B virus e and core proteins. Gastroenterology (1999) 1.52
Cell mediated immune response to the hepatitis C virus. Curr Top Microbiol Immunol (2000) 1.48
Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. J Immunol (1998) 1.44
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J Immunol (1993) 1.40
Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events. J Immunol (1999) 1.34
Th2 cell clonal anergy as a consequence of partial activation. J Exp Med (1994) 1.34
CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability. J Exp Med (2000) 1.29
Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering. J Exp Med (1997) 1.26
Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc Natl Acad Sci U S A (1993) 1.21
Partially phosphorylated T cell receptor zeta molecules can inhibit T cell activation. J Exp Med (1999) 1.16
How alpha beta T-cell receptors 'see' peptide/MHC complexes. Immunol Today (1993) 1.10
Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection. J Immunol (1999) 1.02
CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections. Adv Immunol (1998) 1.01
The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model. J Exp Med (1999) 0.98
Triple immunofluorescence flow cytometry, using whole blood, of CD4+ and CD8+ lymphocytes expressing CD45RO and CD45RA. J Immunol Methods (1993) 0.98
Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. J Virol (1996) 0.94
Characterisation of monoclonal antibodies to human IL-4: application in an IL-4 ELISA and differential inhibition of IL-4 bioactivity on B cells and T cells. Eur Cytokine Netw (1994) 0.85
Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification. Intern Med (1998) 0.84
Partial activation of human T cells by peptide analogs on live APC: induction of clonal anergy associated with protein tyrosine dephosphorylation. Hum Immunol (1997) 0.81
Molecular basis for the lack of T cell proliferation induced by an altered peptide ligand. Int Immunol (1998) 0.78
Immunopathogenesis of HCV infection. Curr Stud Hematol Blood Transfus (1998) 0.77
Interaction of antigenic peptides with MHC and TCR molecules. Clin Immunol Immunopathol (1995) 0.76
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology (1999) 5.79
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet (1995) 4.71
T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today (1999) 4.49
Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol (2001) 4.48
Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol (1998) 3.38
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol (2000) 3.36
Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis (2000) 2.98
Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol (1993) 2.63
Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol (2000) 2.30
[21-year-old patient with recurrent diarrhea, weight loss, leg edema and iron deficiency. Gluten sensitive sprue]. Internist (Berl) (2002) 2.04
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today (1991) 1.89
Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology (1995) 1.72
Cell size of alveolar macrophages: an interspecies comparison. Environ Health Perspect (1997) 1.71
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol (1995) 1.71
Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. J Hepatol (1998) 1.67
Differential antigen-processing pathways of the hepatitis B virus e and core proteins. Gastroenterology (1999) 1.52
Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J Immunol (1999) 1.46
Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol (1995) 1.40
IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells. J Immunol (2000) 1.32
Precore mutant hepatitis B virus infection and liver disease. Gastroenterology (1992) 1.31
High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol (1991) 1.30
Purification, fractionation and assay of antibody-dependent lymphocytic effector cells (K cells) in human blood. Scand J Immunol (1976) 1.27
Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases. Gastroenterology (1983) 1.26
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology (1992) 1.19
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol (1998) 1.19
Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology (1992) 1.15
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure. J Hepatol (1999) 1.14
The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. J Mol Med (Berl) (1996) 1.14
Immune dysregulation in atopic eczema. Arch Dermatol (1992) 1.13
Hepatitis after chronic abuse of senna. Lancet (1991) 1.13
Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol (2000) 1.12
Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells. J Immunol (1996) 1.11
The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy. Clin Exp Allergy (1999) 1.11
Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic area. Virology (1991) 1.10
Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells. J Exp Med (2000) 1.09
Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J Virol (2005) 1.09
Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology (2000) 1.09
Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology (1999) 1.08
Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol (1998) 1.06
Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology (2000) 1.05
Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study. J Immunol (1997) 1.02
Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses. J Viral Hepat (2006) 1.00
T cell epitopes of house dust mite major allergen Der p II. J Immunol (1993) 1.00
Natural cytotoxicity of human Fc gamma-receptor-positive T lymphocytes after surface modulation with immune complexes. Scand J Immunol (1979) 1.00
A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Effective therapy with interferon-alpha. Dig Dis Sci (1995) 0.98
Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture. J Immunol (1977) 0.97
Modulation of T-cell cytokine secretion by accessory cell-derived products. Eur Respir J Suppl (1996) 0.96
Th1 lymphokine production profiles of nickel-specific CD4+T-lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol (1992) 0.96
[Pathological anatomy of Waterhouse-Friderichsen syndrome with special reference to disseminated intravascular coagulation]. Dtsch Med Wochenschr (1973) 0.95
Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease. Eur Respir J (1996) 0.95
Simultaneous occurrence of immunoglobulin-dependent and immunoglobulin-independent mechanisms in natural cytotoxicity of human lymphocytes. J Immunol (1979) 0.94
Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. J Virol (1996) 0.94
Mapping of B-cell epitopes of the human hepatitis B virus X protein. J Virol (1990) 0.93
Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology (1988) 0.93
IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. Eur J Immunol (2001) 0.92
Chronic diarrhea as a result of intestinal microsposidiosis in a liver transplant recipient. Transplantation (2001) 0.91
Food allergen (peanut)-specific TH2 clones generated from the peripheral blood of a patient with peanut allergy. J Allergy Clin Immunol (1996) 0.90
A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists. Pulm Pharmacol Ther (2003) 0.89
Serum levels and in situ expression of TNF-alpha and TNF-alpha binding proteins in inflammatory liver diseases. Cytokine (1996) 0.88
Immunogenicity of human hepatitis B virus P-gene derived proteins. J Immunol (1989) 0.88
Role of type 1 and type 2 T helper cells in allergic diseases. Curr Opin Immunol (1992) 0.87
A scientific relational database combined with a report generator for endoscopy in networks: EndoNet. Endoscopy (1998) 0.87
Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc. J Hepatol (1991) 0.86
Silencer activity of NFATc2 in the interleukin-12 receptor beta 2 proximal promoter in human T helper cells. J Biol Chem (2001) 0.86
Functional maturation of human naive T helper cells in the absence of accessory cells. Generation of IL-4-producing T helper cells does not require exogenous IL-4. J Immunol (1995) 0.85
Production and modulation of T-cell cytokines in atopic allergy. Int Arch Allergy Immunol (1996) 0.85